Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | flibanserin | |
Synonyms |
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one Addyi BIMT 17 BIMT-17 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C098107 |
|
altLabel |
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one Addyi BIMT 17 BIMT-17
|
|
cui |
C0386752 C0754280 C4051421
|
|
HM |
D001562
|
|
Inverse of RB |
37JK4STR6Z 0
|
|
Mapped to | ||
MDA |
20140801
|
|
MeSH Frequency |
166
|
|
MMR |
20161003
|
|
notation |
C098107
|
|
prefLabel |
flibanserin
|
|
RR |
167933-07-5 (flibanserin)
|
|
SC |
1
|
|
Scope Statement |
a 5-HT(2A) receptor antagonist and 5-HT(1A) receptor agonist in rat cerebral cortex; structure given in first source
|
|
SRC |
Naunyn Schmiedebergs Arch Pharmacol 1995 Sep;352(3):276-82
|
|
TERMUI |
T000908682 T287771 T287772 T287773 T287774
|
|
TH |
NLM (1996) NLM (2016) FDA SRS (2013) USAN (19XX) INN (19XX)
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping